Cargando…
Administration Timing and Efficacy of Tocilizumab in Patients With COVID-19 and Elevated IL-6
BACKGROUND: Tocilizumab (TCZ), an interleukin-6 receptor antibody, has previously been used for treating patients with the coronavirus disease 2019 (COVID-19), but there is a lack of data regarding the administration timing of TCZ. OBJECTIVES: This study aimed to evaluate the timing and efficacy of...
Autores principales: | Li, Pan, Lu, Zhengmao, Li, Qiang, Wang, Zhenmeng, Guo, Yan, Cai, Chen, Wang, Shengyun, Liu, Peng, Su, Xiaoping, Huang, Yi, Dong, Yuchao, Qiu, Wenjuan, Ling, Yueming, Yarmus, Lonny, Luo, Fengming, Zeng, Li, Bai, Chong, Zhang, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8084410/ https://www.ncbi.nlm.nih.gov/pubmed/33937333 http://dx.doi.org/10.3389/fmolb.2021.651662 |
Ejemplares similares
-
IL-4/IL-13 Axis in Allergic Rhinitis: Elevated Serum Cytokines Levels and Inverse Association With Tight Junction Molecules Expression
por: Nur Husna, Siti Muhamad, et al.
Publicado: (2022) -
SMARCC1 Enters the Nucleus via KPNA2 and Plays an Oncogenic Role in Bladder Cancer
por: Wei, Zhengmao, et al.
Publicado: (2022) -
Caspase-1 Abrogates the Salutary Effects of Hypertrophic Preconditioning in Pressure Overload Hearts via IL-1β and IL-18
por: Dai, Fangjie, et al.
Publicado: (2021) -
TSPAN4 is a prognostic and immune target in Glioblastoma multiforme
por: Zheng, Yue, et al.
Publicado: (2023) -
Glutamine metabolic reprogramming in hepatocellular carcinoma
por: Ye, Yanyan, et al.
Publicado: (2023)